In the Caribbean, Hispaniola (shared by the Dominican Republic and Haiti), is the only island where malaria remains endemic. Although Puerto Rico eliminated malaria in the mid1950s, reintroduction remains a risk given the presence of competent vectors, such as Anopheles albimanus, as well as travel links to endemic areas, including Hispaniola. 1 For travelers this island, there are several chemoprophylaxis options including chloroquine (CQ), hydroxychloroquine, atovaquone/proguanil, doxycycline, and mefloquine; however, not all travelers take prophylaxis as a precaution.
Between 2000 and 2014, Puerto Rico reported 35 imported cases of malaria, three of which were imported from Hispaniola. 2 In July and August 2015, a cluster of 27 suspected imported cases of malaria was identified by the Puerto Rico Department of Health among travelers returning from Punta Cana, Dominican Republic. In September, two additional patients who traveled to Punta Cana were reported in Puerto Rico and Massachusetts. The patients in all 29 suspected cases did not use malaria chemoprophylaxis despite longstanding Centers for Disease Control and Prevention (CDC) recommendations. Samples from all patients were sent to the CDC for analysis.
Real-time polymerase chain reaction (PCR) confirmed a total of seven Plasmodium falciparum cases among the 29 specimens tested. 2 Further laboratory analysis was undertaken by CDC to characterize the genetic signatures of the Plasmodium sp. parasites present in these samples based on the drug-resistant profile and neutral microsatellite markers. Samples were genotyped by Sanger sequencing for Pfcrt (codons 72-76), Pfdhfr (codons 50, 51, 59, 108, and 164), Pfdhps (codons 436, 437, 540, 581, and 613), Pfmdr-1 (86, 184, 1034, 1042, and 1246), and PfK13 (propeller domain) using an Applied Biosystems 3130 capillary sequencer. [3] [4] [5] Pfmdr-1 copy number was determined by TaqMan real-time PCR (Stratagene MX3005P; Agilent Technologies, La Jolla, CA) using a previously described protocol. 6 Additionally, seven neutral microsatellites [MSTA1 (chromosome 6); MSPoly-α (chr omosome 4); MSPfPK2 (chromosome 12); MSTA109 (chromosome 6); MS2490 (chromosome 10); MSC2M34 (chromosome 2); and MSC3M69 (chromosome 3)] 7,8 were amplified by PCR and analyzed using the GeneMarker software v1.95. These molecular markers have been previously used to characterize clonal lineages in P. falciparum populations from South America, Central America, and Hispaniola. 9 All samples exhibited an identical genetic profile for all drug-resistant markers tested (Table 1) . These samples showed wildtype CQ-sensitive genotype CVMNK in codons 72-76. Similarly, all the isolates carried the sulfadoxinepyrimethamine (SP)-sensitive ancestral wildtype alleles in Pfdhfr and Pfdhps, as well as the wildtype allele for the PfK13 propeller domain, the latter indicating susceptibility to artemisinin (ART). In the Pfmdr-1 gene, a mutation was identified in codon 184 (Y/F), and all samples had a single copy of this gene. The microsatellite data showed that all specimens demonstrated an identical microsatellite profile (A1) with the following alleles: MSTA1: 175, MSPolyα: 151, MSPfPK2: 160, MSTA109: 176, MS2490: 80, MSC2M34: 217, and MSC3M69: 124. The investigation identified a P. falciparum strain with genetic signatures similar to those previously reported from samples originating from Hispaniola as shown by the Bayesian clustering algorithm used in Structure v2.3.4 and depicted in the phylogenetic tree constructed by Populations 1.2.31 and Mega6 (Figure 1 ). The A1 haplotype was similar to other samples present in 2010 9 ; moreover, it belonged to the same cluster with an historic laboratory strain from the late 1970s. This observation suggests the strain found in all seven samples is genetically related to a parasite population that continues to circulate within Hispaniola. 9 Importantly, all parasite isolates exhibited ART, CQ, and SP sensitive wild type genotypes consistent with historic data and indicating that the malaria parasites that continue to be transmitted throughout Hispaniola are sensitive to CQ. Additionally, the microsatellite profile found in these samples was different to the ones previously reported in countries from South America such as Peru, 10 Colombia 11 and Guyana, 5 suggesting a local and independent P. falciparum clonal population in Hispaniola. Recently, a binational agreement has been adopted between the Dominican Republic and Haiti to eliminate malaria by 2020. 12 The Dominican Republic has successfully reduced the number of malaria cases; nevertheless, the ongoing Plasmodium transmission in the island continues to represent a risk for travelers, a majority of which spend their vacations in Punta Cana. Although the efforts to eliminate malaria on the island of Hispaniola will be helpful in minimizing the risk of malaria transmission to travelers, it is important for public health authorities in the Dominican Republic to focus on eliminating ongoing residual malaria transmission in Punta Cana to prevent further transmission of malaria from this region. Finally, it is important for travelers to take steps to prevent the disease when traveling to malaria endemic destinations including use of mosquito avoidance measures and malaria chemoprophylaxis. Sample ID C72S V73 M74I N75E K76T C50R N51I C59R S108N I164L S436A A437G K540E A581G A613S/T N86Y Y184F S1034C N1042D D1246Y 
